In this special summer edition of Search, we take an in depth look at the work our scientists are doing in bringing new treatments to people with cancer, who are at the heart of everything we do. You ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

New study reveals how oesophageal cancer adapts to treatmentThe goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, ...

Twenty years ago, a detailed draft and analysis of the human genome was completed. In this feature, Diana Cano Bordajandi looks at the lasting legacy of the Human Genome Project.

A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one group of men than the current standard blood test, a new study reports.

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

The first patient has been treated, as part of a clinical trial, with an innovative new technology called Acoustic Cluster Therapy that uses microscopic clusters of bubbles and liquid droplets to ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous.